New Frontiers Psychiatric Sc - Medicare Mental Health Clinic in Milwaukee, WI

New Frontiers Psychiatric Sc is a medicare enrolled mental health clinic (Psychiatry & Neurology - Psychiatry) in Milwaukee, Wisconsin. The current practice location for New Frontiers Psychiatric Sc is 2675 N Mayfair Rd Ste 400, Milwaukee, Wisconsin. For appointments, you can reach them via phone at (414) 763-6910. The mailing address for New Frontiers Psychiatric Sc is 2675 N Mayfair Rd Ste 400, Milwaukee, Wisconsin and phone number is (414) 763-6910.

New Frontiers Psychiatric Sc is licensed to practice in * (Not Available) (license number ). The clinic also participates in the medicare program and its NPI number is 1003390394. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (414) 763-6910.

Contact Information

New Frontiers Psychiatric Sc
2675 N Mayfair Rd Ste 400
Milwaukee
WI 53226-1305
(414) 763-6910
(414) 763-6911

Mental Health Clinic Profile

Full NameNew Frontiers Psychiatric Sc
SpecialityPsychiatry & Neurology
Location2675 N Mayfair Rd Ste 400, Milwaukee, Wisconsin
Authorized Official Name and PositionHong Yin (PRESIDENT)
Authorized Official Contact4147636910
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
New Frontiers Psychiatric Sc
2675 N Mayfair Rd Ste 400
Milwaukee
WI 53226-1305

Ph: (414) 763-6910
New Frontiers Psychiatric Sc
2675 N Mayfair Rd Ste 400
Milwaukee
WI 53226-1305

Ph: (414) 763-6910

NPI Details:

NPI Number1003390394
Provider Enumeration Date09/21/2018
Last Update Date10/23/2018

Medicare PECOS Information:

Medicare PECOS PAC ID7416201058
Medicare Enrollment IDO20181116001317

News Archive

FDA grants final approval to Breckenridge's Pioglitazone Hydrochloride ANDA

Breckenridge Pharmaceutical, Inc. announced today the immediate launch of Pioglitazone Hydrochloride Tablets. The U.S. Food and Drug Administration granted final approval for the Abbreviated New Drug Application (ANDA), which is being manufactured and supplied by Synthon Pharmaceuticals, Inc., and will be available in 15 mg, 30 mg, and 45 mg strengths.

MDD with subthreshold hypomania ‘should be merged with bipolar II'

Patients with major depressive disorder plus subthreshold hypomania exhibit significant differences in disease course, symptoms, treatment-seeking rates, and other characteristics compared with those with major depression alone, research shows.

G8 should discuss world's over-60 population to develop policies for 'healthy, active and productive aging'

"Within five years, for the first time in history, the number of adults 65 and older will exceed the number of children younger than five, the World Health Organization reports," "which is why the aging global population's impact on social stability, economic growth and fiscal sustainability should be part of the agenda at next month's Group of Eight summit," Michael Hodin, an adjunct senior fellow at the Council on Foreign Relations and executive director of the Global Coalition on Aging, writes in a Washington Post opinion piece.

Study uncovers encouraging news for rural and remote stroke patients in Australia

World-first research has uncovered encouraging news for rural and remote Australians who suffer a stroke.

New technique can help predict and combat potential pandemic virus

By developing a new technique for labeling the gene segments of influenza viruses, researchers now know more about how influenza viruses enter the cell and establish cell co-infections - a major contributing factor to potential pandemic development.

Read more Medical News

› Verified 2 days ago

Medical Identifiers

Medical identifiers for New Frontiers Psychiatric Sc such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1003390394NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
2084P0800XPsychiatry & Neurology - Psychiatry (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. New Frontiers Psychiatric Sc acts as a billing entity for following providers:
Provider NameMindas V Siliunas
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1417976747
PECOS PAC ID: 4688695232
Enrollment ID: I20051212000489

News Archive

FDA grants final approval to Breckenridge's Pioglitazone Hydrochloride ANDA

Breckenridge Pharmaceutical, Inc. announced today the immediate launch of Pioglitazone Hydrochloride Tablets. The U.S. Food and Drug Administration granted final approval for the Abbreviated New Drug Application (ANDA), which is being manufactured and supplied by Synthon Pharmaceuticals, Inc., and will be available in 15 mg, 30 mg, and 45 mg strengths.

MDD with subthreshold hypomania ‘should be merged with bipolar II'

Patients with major depressive disorder plus subthreshold hypomania exhibit significant differences in disease course, symptoms, treatment-seeking rates, and other characteristics compared with those with major depression alone, research shows.

G8 should discuss world's over-60 population to develop policies for 'healthy, active and productive aging'

"Within five years, for the first time in history, the number of adults 65 and older will exceed the number of children younger than five, the World Health Organization reports," "which is why the aging global population's impact on social stability, economic growth and fiscal sustainability should be part of the agenda at next month's Group of Eight summit," Michael Hodin, an adjunct senior fellow at the Council on Foreign Relations and executive director of the Global Coalition on Aging, writes in a Washington Post opinion piece.

Study uncovers encouraging news for rural and remote stroke patients in Australia

World-first research has uncovered encouraging news for rural and remote Australians who suffer a stroke.

New technique can help predict and combat potential pandemic virus

By developing a new technique for labeling the gene segments of influenza viruses, researchers now know more about how influenza viruses enter the cell and establish cell co-infections - a major contributing factor to potential pandemic development.

Read more Medical News

› Verified 2 days ago

Provider NameHeidi Heimler
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1972613016
PECOS PAC ID: 8820007891
Enrollment ID: I20060419000596

News Archive

FDA grants final approval to Breckenridge's Pioglitazone Hydrochloride ANDA

Breckenridge Pharmaceutical, Inc. announced today the immediate launch of Pioglitazone Hydrochloride Tablets. The U.S. Food and Drug Administration granted final approval for the Abbreviated New Drug Application (ANDA), which is being manufactured and supplied by Synthon Pharmaceuticals, Inc., and will be available in 15 mg, 30 mg, and 45 mg strengths.

MDD with subthreshold hypomania ‘should be merged with bipolar II'

Patients with major depressive disorder plus subthreshold hypomania exhibit significant differences in disease course, symptoms, treatment-seeking rates, and other characteristics compared with those with major depression alone, research shows.

G8 should discuss world's over-60 population to develop policies for 'healthy, active and productive aging'

"Within five years, for the first time in history, the number of adults 65 and older will exceed the number of children younger than five, the World Health Organization reports," "which is why the aging global population's impact on social stability, economic growth and fiscal sustainability should be part of the agenda at next month's Group of Eight summit," Michael Hodin, an adjunct senior fellow at the Council on Foreign Relations and executive director of the Global Coalition on Aging, writes in a Washington Post opinion piece.

Study uncovers encouraging news for rural and remote stroke patients in Australia

World-first research has uncovered encouraging news for rural and remote Australians who suffer a stroke.

New technique can help predict and combat potential pandemic virus

By developing a new technique for labeling the gene segments of influenza viruses, researchers now know more about how influenza viruses enter the cell and establish cell co-infections - a major contributing factor to potential pandemic development.

Read more Medical News

› Verified 2 days ago

Provider NameLisa Marie Collingwood
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1134158751
PECOS PAC ID: 6507840527
Enrollment ID: I20140117000847

News Archive

FDA grants final approval to Breckenridge's Pioglitazone Hydrochloride ANDA

Breckenridge Pharmaceutical, Inc. announced today the immediate launch of Pioglitazone Hydrochloride Tablets. The U.S. Food and Drug Administration granted final approval for the Abbreviated New Drug Application (ANDA), which is being manufactured and supplied by Synthon Pharmaceuticals, Inc., and will be available in 15 mg, 30 mg, and 45 mg strengths.

MDD with subthreshold hypomania ‘should be merged with bipolar II'

Patients with major depressive disorder plus subthreshold hypomania exhibit significant differences in disease course, symptoms, treatment-seeking rates, and other characteristics compared with those with major depression alone, research shows.

G8 should discuss world's over-60 population to develop policies for 'healthy, active and productive aging'

"Within five years, for the first time in history, the number of adults 65 and older will exceed the number of children younger than five, the World Health Organization reports," "which is why the aging global population's impact on social stability, economic growth and fiscal sustainability should be part of the agenda at next month's Group of Eight summit," Michael Hodin, an adjunct senior fellow at the Council on Foreign Relations and executive director of the Global Coalition on Aging, writes in a Washington Post opinion piece.

Study uncovers encouraging news for rural and remote stroke patients in Australia

World-first research has uncovered encouraging news for rural and remote Australians who suffer a stroke.

New technique can help predict and combat potential pandemic virus

By developing a new technique for labeling the gene segments of influenza viruses, researchers now know more about how influenza viruses enter the cell and establish cell co-infections - a major contributing factor to potential pandemic development.

Read more Medical News

› Verified 2 days ago

Provider NameOlivia Bruss
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1518361187
PECOS PAC ID: 3577885789
Enrollment ID: I20141125000856

News Archive

FDA grants final approval to Breckenridge's Pioglitazone Hydrochloride ANDA

Breckenridge Pharmaceutical, Inc. announced today the immediate launch of Pioglitazone Hydrochloride Tablets. The U.S. Food and Drug Administration granted final approval for the Abbreviated New Drug Application (ANDA), which is being manufactured and supplied by Synthon Pharmaceuticals, Inc., and will be available in 15 mg, 30 mg, and 45 mg strengths.

MDD with subthreshold hypomania ‘should be merged with bipolar II'

Patients with major depressive disorder plus subthreshold hypomania exhibit significant differences in disease course, symptoms, treatment-seeking rates, and other characteristics compared with those with major depression alone, research shows.

G8 should discuss world's over-60 population to develop policies for 'healthy, active and productive aging'

"Within five years, for the first time in history, the number of adults 65 and older will exceed the number of children younger than five, the World Health Organization reports," "which is why the aging global population's impact on social stability, economic growth and fiscal sustainability should be part of the agenda at next month's Group of Eight summit," Michael Hodin, an adjunct senior fellow at the Council on Foreign Relations and executive director of the Global Coalition on Aging, writes in a Washington Post opinion piece.

Study uncovers encouraging news for rural and remote stroke patients in Australia

World-first research has uncovered encouraging news for rural and remote Australians who suffer a stroke.

New technique can help predict and combat potential pandemic virus

By developing a new technique for labeling the gene segments of influenza viruses, researchers now know more about how influenza viruses enter the cell and establish cell co-infections - a major contributing factor to potential pandemic development.

Read more Medical News

› Verified 2 days ago

Provider NameChristina M Brigham
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1467796433
PECOS PAC ID: 7113244872
Enrollment ID: I20150318001303

News Archive

FDA grants final approval to Breckenridge's Pioglitazone Hydrochloride ANDA

Breckenridge Pharmaceutical, Inc. announced today the immediate launch of Pioglitazone Hydrochloride Tablets. The U.S. Food and Drug Administration granted final approval for the Abbreviated New Drug Application (ANDA), which is being manufactured and supplied by Synthon Pharmaceuticals, Inc., and will be available in 15 mg, 30 mg, and 45 mg strengths.

MDD with subthreshold hypomania ‘should be merged with bipolar II'

Patients with major depressive disorder plus subthreshold hypomania exhibit significant differences in disease course, symptoms, treatment-seeking rates, and other characteristics compared with those with major depression alone, research shows.

G8 should discuss world's over-60 population to develop policies for 'healthy, active and productive aging'

"Within five years, for the first time in history, the number of adults 65 and older will exceed the number of children younger than five, the World Health Organization reports," "which is why the aging global population's impact on social stability, economic growth and fiscal sustainability should be part of the agenda at next month's Group of Eight summit," Michael Hodin, an adjunct senior fellow at the Council on Foreign Relations and executive director of the Global Coalition on Aging, writes in a Washington Post opinion piece.

Study uncovers encouraging news for rural and remote stroke patients in Australia

World-first research has uncovered encouraging news for rural and remote Australians who suffer a stroke.

New technique can help predict and combat potential pandemic virus

By developing a new technique for labeling the gene segments of influenza viruses, researchers now know more about how influenza viruses enter the cell and establish cell co-infections - a major contributing factor to potential pandemic development.

Read more Medical News

› Verified 2 days ago

Provider NameHong Yin
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1669780060
PECOS PAC ID: 6103145743
Enrollment ID: I20160719001362

News Archive

FDA grants final approval to Breckenridge's Pioglitazone Hydrochloride ANDA

Breckenridge Pharmaceutical, Inc. announced today the immediate launch of Pioglitazone Hydrochloride Tablets. The U.S. Food and Drug Administration granted final approval for the Abbreviated New Drug Application (ANDA), which is being manufactured and supplied by Synthon Pharmaceuticals, Inc., and will be available in 15 mg, 30 mg, and 45 mg strengths.

MDD with subthreshold hypomania ‘should be merged with bipolar II'

Patients with major depressive disorder plus subthreshold hypomania exhibit significant differences in disease course, symptoms, treatment-seeking rates, and other characteristics compared with those with major depression alone, research shows.

G8 should discuss world's over-60 population to develop policies for 'healthy, active and productive aging'

"Within five years, for the first time in history, the number of adults 65 and older will exceed the number of children younger than five, the World Health Organization reports," "which is why the aging global population's impact on social stability, economic growth and fiscal sustainability should be part of the agenda at next month's Group of Eight summit," Michael Hodin, an adjunct senior fellow at the Council on Foreign Relations and executive director of the Global Coalition on Aging, writes in a Washington Post opinion piece.

Study uncovers encouraging news for rural and remote stroke patients in Australia

World-first research has uncovered encouraging news for rural and remote Australians who suffer a stroke.

New technique can help predict and combat potential pandemic virus

By developing a new technique for labeling the gene segments of influenza viruses, researchers now know more about how influenza viruses enter the cell and establish cell co-infections - a major contributing factor to potential pandemic development.

Read more Medical News

› Verified 2 days ago

Provider NameDavid Radovich
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1649588872
PECOS PAC ID: 4486922994
Enrollment ID: I20170623001767

News Archive

FDA grants final approval to Breckenridge's Pioglitazone Hydrochloride ANDA

Breckenridge Pharmaceutical, Inc. announced today the immediate launch of Pioglitazone Hydrochloride Tablets. The U.S. Food and Drug Administration granted final approval for the Abbreviated New Drug Application (ANDA), which is being manufactured and supplied by Synthon Pharmaceuticals, Inc., and will be available in 15 mg, 30 mg, and 45 mg strengths.

MDD with subthreshold hypomania ‘should be merged with bipolar II'

Patients with major depressive disorder plus subthreshold hypomania exhibit significant differences in disease course, symptoms, treatment-seeking rates, and other characteristics compared with those with major depression alone, research shows.

G8 should discuss world's over-60 population to develop policies for 'healthy, active and productive aging'

"Within five years, for the first time in history, the number of adults 65 and older will exceed the number of children younger than five, the World Health Organization reports," "which is why the aging global population's impact on social stability, economic growth and fiscal sustainability should be part of the agenda at next month's Group of Eight summit," Michael Hodin, an adjunct senior fellow at the Council on Foreign Relations and executive director of the Global Coalition on Aging, writes in a Washington Post opinion piece.

Study uncovers encouraging news for rural and remote stroke patients in Australia

World-first research has uncovered encouraging news for rural and remote Australians who suffer a stroke.

New technique can help predict and combat potential pandemic virus

By developing a new technique for labeling the gene segments of influenza viruses, researchers now know more about how influenza viruses enter the cell and establish cell co-infections - a major contributing factor to potential pandemic development.

Read more Medical News

› Verified 2 days ago

Provider NameAbigail I Ruh
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1235508748
PECOS PAC ID: 2466713748
Enrollment ID: I20180301000561

News Archive

FDA grants final approval to Breckenridge's Pioglitazone Hydrochloride ANDA

Breckenridge Pharmaceutical, Inc. announced today the immediate launch of Pioglitazone Hydrochloride Tablets. The U.S. Food and Drug Administration granted final approval for the Abbreviated New Drug Application (ANDA), which is being manufactured and supplied by Synthon Pharmaceuticals, Inc., and will be available in 15 mg, 30 mg, and 45 mg strengths.

MDD with subthreshold hypomania ‘should be merged with bipolar II'

Patients with major depressive disorder plus subthreshold hypomania exhibit significant differences in disease course, symptoms, treatment-seeking rates, and other characteristics compared with those with major depression alone, research shows.

G8 should discuss world's over-60 population to develop policies for 'healthy, active and productive aging'

"Within five years, for the first time in history, the number of adults 65 and older will exceed the number of children younger than five, the World Health Organization reports," "which is why the aging global population's impact on social stability, economic growth and fiscal sustainability should be part of the agenda at next month's Group of Eight summit," Michael Hodin, an adjunct senior fellow at the Council on Foreign Relations and executive director of the Global Coalition on Aging, writes in a Washington Post opinion piece.

Study uncovers encouraging news for rural and remote stroke patients in Australia

World-first research has uncovered encouraging news for rural and remote Australians who suffer a stroke.

New technique can help predict and combat potential pandemic virus

By developing a new technique for labeling the gene segments of influenza viruses, researchers now know more about how influenza viruses enter the cell and establish cell co-infections - a major contributing factor to potential pandemic development.

Read more Medical News

› Verified 2 days ago

Provider NameSarah V Hoerl
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1134502743
PECOS PAC ID: 0749544500
Enrollment ID: I20180502000486

News Archive

FDA grants final approval to Breckenridge's Pioglitazone Hydrochloride ANDA

Breckenridge Pharmaceutical, Inc. announced today the immediate launch of Pioglitazone Hydrochloride Tablets. The U.S. Food and Drug Administration granted final approval for the Abbreviated New Drug Application (ANDA), which is being manufactured and supplied by Synthon Pharmaceuticals, Inc., and will be available in 15 mg, 30 mg, and 45 mg strengths.

MDD with subthreshold hypomania ‘should be merged with bipolar II'

Patients with major depressive disorder plus subthreshold hypomania exhibit significant differences in disease course, symptoms, treatment-seeking rates, and other characteristics compared with those with major depression alone, research shows.

G8 should discuss world's over-60 population to develop policies for 'healthy, active and productive aging'

"Within five years, for the first time in history, the number of adults 65 and older will exceed the number of children younger than five, the World Health Organization reports," "which is why the aging global population's impact on social stability, economic growth and fiscal sustainability should be part of the agenda at next month's Group of Eight summit," Michael Hodin, an adjunct senior fellow at the Council on Foreign Relations and executive director of the Global Coalition on Aging, writes in a Washington Post opinion piece.

Study uncovers encouraging news for rural and remote stroke patients in Australia

World-first research has uncovered encouraging news for rural and remote Australians who suffer a stroke.

New technique can help predict and combat potential pandemic virus

By developing a new technique for labeling the gene segments of influenza viruses, researchers now know more about how influenza viruses enter the cell and establish cell co-infections - a major contributing factor to potential pandemic development.

Read more Medical News

› Verified 2 days ago

Provider NameJoanna R Love
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1366741480
PECOS PAC ID: 3375881642
Enrollment ID: I20190212000590

News Archive

FDA grants final approval to Breckenridge's Pioglitazone Hydrochloride ANDA

Breckenridge Pharmaceutical, Inc. announced today the immediate launch of Pioglitazone Hydrochloride Tablets. The U.S. Food and Drug Administration granted final approval for the Abbreviated New Drug Application (ANDA), which is being manufactured and supplied by Synthon Pharmaceuticals, Inc., and will be available in 15 mg, 30 mg, and 45 mg strengths.

MDD with subthreshold hypomania ‘should be merged with bipolar II'

Patients with major depressive disorder plus subthreshold hypomania exhibit significant differences in disease course, symptoms, treatment-seeking rates, and other characteristics compared with those with major depression alone, research shows.

G8 should discuss world's over-60 population to develop policies for 'healthy, active and productive aging'

"Within five years, for the first time in history, the number of adults 65 and older will exceed the number of children younger than five, the World Health Organization reports," "which is why the aging global population's impact on social stability, economic growth and fiscal sustainability should be part of the agenda at next month's Group of Eight summit," Michael Hodin, an adjunct senior fellow at the Council on Foreign Relations and executive director of the Global Coalition on Aging, writes in a Washington Post opinion piece.

Study uncovers encouraging news for rural and remote stroke patients in Australia

World-first research has uncovered encouraging news for rural and remote Australians who suffer a stroke.

New technique can help predict and combat potential pandemic virus

By developing a new technique for labeling the gene segments of influenza viruses, researchers now know more about how influenza viruses enter the cell and establish cell co-infections - a major contributing factor to potential pandemic development.

Read more Medical News

› Verified 2 days ago

Provider NameMarian G Obrien-frigo
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1518992650
PECOS PAC ID: 8224370747
Enrollment ID: I20190503000212

News Archive

FDA grants final approval to Breckenridge's Pioglitazone Hydrochloride ANDA

Breckenridge Pharmaceutical, Inc. announced today the immediate launch of Pioglitazone Hydrochloride Tablets. The U.S. Food and Drug Administration granted final approval for the Abbreviated New Drug Application (ANDA), which is being manufactured and supplied by Synthon Pharmaceuticals, Inc., and will be available in 15 mg, 30 mg, and 45 mg strengths.

MDD with subthreshold hypomania ‘should be merged with bipolar II'

Patients with major depressive disorder plus subthreshold hypomania exhibit significant differences in disease course, symptoms, treatment-seeking rates, and other characteristics compared with those with major depression alone, research shows.

G8 should discuss world's over-60 population to develop policies for 'healthy, active and productive aging'

"Within five years, for the first time in history, the number of adults 65 and older will exceed the number of children younger than five, the World Health Organization reports," "which is why the aging global population's impact on social stability, economic growth and fiscal sustainability should be part of the agenda at next month's Group of Eight summit," Michael Hodin, an adjunct senior fellow at the Council on Foreign Relations and executive director of the Global Coalition on Aging, writes in a Washington Post opinion piece.

Study uncovers encouraging news for rural and remote stroke patients in Australia

World-first research has uncovered encouraging news for rural and remote Australians who suffer a stroke.

New technique can help predict and combat potential pandemic virus

By developing a new technique for labeling the gene segments of influenza viruses, researchers now know more about how influenza viruses enter the cell and establish cell co-infections - a major contributing factor to potential pandemic development.

Read more Medical News

› Verified 2 days ago

Provider NameCourtney J Weston
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1184268229
PECOS PAC ID: 9133552177
Enrollment ID: I20191205002630

News Archive

FDA grants final approval to Breckenridge's Pioglitazone Hydrochloride ANDA

Breckenridge Pharmaceutical, Inc. announced today the immediate launch of Pioglitazone Hydrochloride Tablets. The U.S. Food and Drug Administration granted final approval for the Abbreviated New Drug Application (ANDA), which is being manufactured and supplied by Synthon Pharmaceuticals, Inc., and will be available in 15 mg, 30 mg, and 45 mg strengths.

MDD with subthreshold hypomania ‘should be merged with bipolar II'

Patients with major depressive disorder plus subthreshold hypomania exhibit significant differences in disease course, symptoms, treatment-seeking rates, and other characteristics compared with those with major depression alone, research shows.

G8 should discuss world's over-60 population to develop policies for 'healthy, active and productive aging'

"Within five years, for the first time in history, the number of adults 65 and older will exceed the number of children younger than five, the World Health Organization reports," "which is why the aging global population's impact on social stability, economic growth and fiscal sustainability should be part of the agenda at next month's Group of Eight summit," Michael Hodin, an adjunct senior fellow at the Council on Foreign Relations and executive director of the Global Coalition on Aging, writes in a Washington Post opinion piece.

Study uncovers encouraging news for rural and remote stroke patients in Australia

World-first research has uncovered encouraging news for rural and remote Australians who suffer a stroke.

New technique can help predict and combat potential pandemic virus

By developing a new technique for labeling the gene segments of influenza viruses, researchers now know more about how influenza viruses enter the cell and establish cell co-infections - a major contributing factor to potential pandemic development.

Read more Medical News

› Verified 2 days ago

Provider NameLeticia G Vallejo
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1477114304
PECOS PAC ID: 1355776139
Enrollment ID: I20200124001968

News Archive

FDA grants final approval to Breckenridge's Pioglitazone Hydrochloride ANDA

Breckenridge Pharmaceutical, Inc. announced today the immediate launch of Pioglitazone Hydrochloride Tablets. The U.S. Food and Drug Administration granted final approval for the Abbreviated New Drug Application (ANDA), which is being manufactured and supplied by Synthon Pharmaceuticals, Inc., and will be available in 15 mg, 30 mg, and 45 mg strengths.

MDD with subthreshold hypomania ‘should be merged with bipolar II'

Patients with major depressive disorder plus subthreshold hypomania exhibit significant differences in disease course, symptoms, treatment-seeking rates, and other characteristics compared with those with major depression alone, research shows.

G8 should discuss world's over-60 population to develop policies for 'healthy, active and productive aging'

"Within five years, for the first time in history, the number of adults 65 and older will exceed the number of children younger than five, the World Health Organization reports," "which is why the aging global population's impact on social stability, economic growth and fiscal sustainability should be part of the agenda at next month's Group of Eight summit," Michael Hodin, an adjunct senior fellow at the Council on Foreign Relations and executive director of the Global Coalition on Aging, writes in a Washington Post opinion piece.

Study uncovers encouraging news for rural and remote stroke patients in Australia

World-first research has uncovered encouraging news for rural and remote Australians who suffer a stroke.

New technique can help predict and combat potential pandemic virus

By developing a new technique for labeling the gene segments of influenza viruses, researchers now know more about how influenza viruses enter the cell and establish cell co-infections - a major contributing factor to potential pandemic development.

Read more Medical News

› Verified 2 days ago

Provider NameLeah L O'reilly
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1366823635
PECOS PAC ID: 1153758669
Enrollment ID: I20200224000305

News Archive

FDA grants final approval to Breckenridge's Pioglitazone Hydrochloride ANDA

Breckenridge Pharmaceutical, Inc. announced today the immediate launch of Pioglitazone Hydrochloride Tablets. The U.S. Food and Drug Administration granted final approval for the Abbreviated New Drug Application (ANDA), which is being manufactured and supplied by Synthon Pharmaceuticals, Inc., and will be available in 15 mg, 30 mg, and 45 mg strengths.

MDD with subthreshold hypomania ‘should be merged with bipolar II'

Patients with major depressive disorder plus subthreshold hypomania exhibit significant differences in disease course, symptoms, treatment-seeking rates, and other characteristics compared with those with major depression alone, research shows.

G8 should discuss world's over-60 population to develop policies for 'healthy, active and productive aging'

"Within five years, for the first time in history, the number of adults 65 and older will exceed the number of children younger than five, the World Health Organization reports," "which is why the aging global population's impact on social stability, economic growth and fiscal sustainability should be part of the agenda at next month's Group of Eight summit," Michael Hodin, an adjunct senior fellow at the Council on Foreign Relations and executive director of the Global Coalition on Aging, writes in a Washington Post opinion piece.

Study uncovers encouraging news for rural and remote stroke patients in Australia

World-first research has uncovered encouraging news for rural and remote Australians who suffer a stroke.

New technique can help predict and combat potential pandemic virus

By developing a new technique for labeling the gene segments of influenza viruses, researchers now know more about how influenza viruses enter the cell and establish cell co-infections - a major contributing factor to potential pandemic development.

Read more Medical News

› Verified 2 days ago

Provider NameDomantas Mikonis
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1891149944
PECOS PAC ID: 9436495066
Enrollment ID: I20201016001195

News Archive

FDA grants final approval to Breckenridge's Pioglitazone Hydrochloride ANDA

Breckenridge Pharmaceutical, Inc. announced today the immediate launch of Pioglitazone Hydrochloride Tablets. The U.S. Food and Drug Administration granted final approval for the Abbreviated New Drug Application (ANDA), which is being manufactured and supplied by Synthon Pharmaceuticals, Inc., and will be available in 15 mg, 30 mg, and 45 mg strengths.

MDD with subthreshold hypomania ‘should be merged with bipolar II'

Patients with major depressive disorder plus subthreshold hypomania exhibit significant differences in disease course, symptoms, treatment-seeking rates, and other characteristics compared with those with major depression alone, research shows.

G8 should discuss world's over-60 population to develop policies for 'healthy, active and productive aging'

"Within five years, for the first time in history, the number of adults 65 and older will exceed the number of children younger than five, the World Health Organization reports," "which is why the aging global population's impact on social stability, economic growth and fiscal sustainability should be part of the agenda at next month's Group of Eight summit," Michael Hodin, an adjunct senior fellow at the Council on Foreign Relations and executive director of the Global Coalition on Aging, writes in a Washington Post opinion piece.

Study uncovers encouraging news for rural and remote stroke patients in Australia

World-first research has uncovered encouraging news for rural and remote Australians who suffer a stroke.

New technique can help predict and combat potential pandemic virus

By developing a new technique for labeling the gene segments of influenza viruses, researchers now know more about how influenza viruses enter the cell and establish cell co-infections - a major contributing factor to potential pandemic development.

Read more Medical News

› Verified 2 days ago

Provider NameJennifer Ha
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1093008666
PECOS PAC ID: 5092078758
Enrollment ID: I20210824003470

News Archive

FDA grants final approval to Breckenridge's Pioglitazone Hydrochloride ANDA

Breckenridge Pharmaceutical, Inc. announced today the immediate launch of Pioglitazone Hydrochloride Tablets. The U.S. Food and Drug Administration granted final approval for the Abbreviated New Drug Application (ANDA), which is being manufactured and supplied by Synthon Pharmaceuticals, Inc., and will be available in 15 mg, 30 mg, and 45 mg strengths.

MDD with subthreshold hypomania ‘should be merged with bipolar II'

Patients with major depressive disorder plus subthreshold hypomania exhibit significant differences in disease course, symptoms, treatment-seeking rates, and other characteristics compared with those with major depression alone, research shows.

G8 should discuss world's over-60 population to develop policies for 'healthy, active and productive aging'

"Within five years, for the first time in history, the number of adults 65 and older will exceed the number of children younger than five, the World Health Organization reports," "which is why the aging global population's impact on social stability, economic growth and fiscal sustainability should be part of the agenda at next month's Group of Eight summit," Michael Hodin, an adjunct senior fellow at the Council on Foreign Relations and executive director of the Global Coalition on Aging, writes in a Washington Post opinion piece.

Study uncovers encouraging news for rural and remote stroke patients in Australia

World-first research has uncovered encouraging news for rural and remote Australians who suffer a stroke.

New technique can help predict and combat potential pandemic virus

By developing a new technique for labeling the gene segments of influenza viruses, researchers now know more about how influenza viruses enter the cell and establish cell co-infections - a major contributing factor to potential pandemic development.

Read more Medical News

› Verified 2 days ago

Provider NameLori Ann Garfinkel
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1619558806
PECOS PAC ID: 6305231846
Enrollment ID: I20220318000789

News Archive

FDA grants final approval to Breckenridge's Pioglitazone Hydrochloride ANDA

Breckenridge Pharmaceutical, Inc. announced today the immediate launch of Pioglitazone Hydrochloride Tablets. The U.S. Food and Drug Administration granted final approval for the Abbreviated New Drug Application (ANDA), which is being manufactured and supplied by Synthon Pharmaceuticals, Inc., and will be available in 15 mg, 30 mg, and 45 mg strengths.

MDD with subthreshold hypomania ‘should be merged with bipolar II'

Patients with major depressive disorder plus subthreshold hypomania exhibit significant differences in disease course, symptoms, treatment-seeking rates, and other characteristics compared with those with major depression alone, research shows.

G8 should discuss world's over-60 population to develop policies for 'healthy, active and productive aging'

"Within five years, for the first time in history, the number of adults 65 and older will exceed the number of children younger than five, the World Health Organization reports," "which is why the aging global population's impact on social stability, economic growth and fiscal sustainability should be part of the agenda at next month's Group of Eight summit," Michael Hodin, an adjunct senior fellow at the Council on Foreign Relations and executive director of the Global Coalition on Aging, writes in a Washington Post opinion piece.

Study uncovers encouraging news for rural and remote stroke patients in Australia

World-first research has uncovered encouraging news for rural and remote Australians who suffer a stroke.

New technique can help predict and combat potential pandemic virus

By developing a new technique for labeling the gene segments of influenza viruses, researchers now know more about how influenza viruses enter the cell and establish cell co-infections - a major contributing factor to potential pandemic development.

Read more Medical News

› Verified 2 days ago

Provider NameKavitha Dharmalingam Venkateswaran
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1023655362
PECOS PAC ID: 9638548472
Enrollment ID: I20221216002040

News Archive

FDA grants final approval to Breckenridge's Pioglitazone Hydrochloride ANDA

Breckenridge Pharmaceutical, Inc. announced today the immediate launch of Pioglitazone Hydrochloride Tablets. The U.S. Food and Drug Administration granted final approval for the Abbreviated New Drug Application (ANDA), which is being manufactured and supplied by Synthon Pharmaceuticals, Inc., and will be available in 15 mg, 30 mg, and 45 mg strengths.

MDD with subthreshold hypomania ‘should be merged with bipolar II'

Patients with major depressive disorder plus subthreshold hypomania exhibit significant differences in disease course, symptoms, treatment-seeking rates, and other characteristics compared with those with major depression alone, research shows.

G8 should discuss world's over-60 population to develop policies for 'healthy, active and productive aging'

"Within five years, for the first time in history, the number of adults 65 and older will exceed the number of children younger than five, the World Health Organization reports," "which is why the aging global population's impact on social stability, economic growth and fiscal sustainability should be part of the agenda at next month's Group of Eight summit," Michael Hodin, an adjunct senior fellow at the Council on Foreign Relations and executive director of the Global Coalition on Aging, writes in a Washington Post opinion piece.

Study uncovers encouraging news for rural and remote stroke patients in Australia

World-first research has uncovered encouraging news for rural and remote Australians who suffer a stroke.

New technique can help predict and combat potential pandemic virus

By developing a new technique for labeling the gene segments of influenza viruses, researchers now know more about how influenza viruses enter the cell and establish cell co-infections - a major contributing factor to potential pandemic development.

Read more Medical News

› Verified 2 days ago

Provider NameBrian Michael Flynn
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1790021897
PECOS PAC ID: 7810360955
Enrollment ID: I20230310000741

News Archive

FDA grants final approval to Breckenridge's Pioglitazone Hydrochloride ANDA

Breckenridge Pharmaceutical, Inc. announced today the immediate launch of Pioglitazone Hydrochloride Tablets. The U.S. Food and Drug Administration granted final approval for the Abbreviated New Drug Application (ANDA), which is being manufactured and supplied by Synthon Pharmaceuticals, Inc., and will be available in 15 mg, 30 mg, and 45 mg strengths.

MDD with subthreshold hypomania ‘should be merged with bipolar II'

Patients with major depressive disorder plus subthreshold hypomania exhibit significant differences in disease course, symptoms, treatment-seeking rates, and other characteristics compared with those with major depression alone, research shows.

G8 should discuss world's over-60 population to develop policies for 'healthy, active and productive aging'

"Within five years, for the first time in history, the number of adults 65 and older will exceed the number of children younger than five, the World Health Organization reports," "which is why the aging global population's impact on social stability, economic growth and fiscal sustainability should be part of the agenda at next month's Group of Eight summit," Michael Hodin, an adjunct senior fellow at the Council on Foreign Relations and executive director of the Global Coalition on Aging, writes in a Washington Post opinion piece.

Study uncovers encouraging news for rural and remote stroke patients in Australia

World-first research has uncovered encouraging news for rural and remote Australians who suffer a stroke.

New technique can help predict and combat potential pandemic virus

By developing a new technique for labeling the gene segments of influenza viruses, researchers now know more about how influenza viruses enter the cell and establish cell co-infections - a major contributing factor to potential pandemic development.

Read more Medical News

› Verified 2 days ago

News Archive

FDA grants final approval to Breckenridge's Pioglitazone Hydrochloride ANDA

Breckenridge Pharmaceutical, Inc. announced today the immediate launch of Pioglitazone Hydrochloride Tablets. The U.S. Food and Drug Administration granted final approval for the Abbreviated New Drug Application (ANDA), which is being manufactured and supplied by Synthon Pharmaceuticals, Inc., and will be available in 15 mg, 30 mg, and 45 mg strengths.

MDD with subthreshold hypomania ‘should be merged with bipolar II'

Patients with major depressive disorder plus subthreshold hypomania exhibit significant differences in disease course, symptoms, treatment-seeking rates, and other characteristics compared with those with major depression alone, research shows.

G8 should discuss world's over-60 population to develop policies for 'healthy, active and productive aging'

"Within five years, for the first time in history, the number of adults 65 and older will exceed the number of children younger than five, the World Health Organization reports," "which is why the aging global population's impact on social stability, economic growth and fiscal sustainability should be part of the agenda at next month's Group of Eight summit," Michael Hodin, an adjunct senior fellow at the Council on Foreign Relations and executive director of the Global Coalition on Aging, writes in a Washington Post opinion piece.

Study uncovers encouraging news for rural and remote stroke patients in Australia

World-first research has uncovered encouraging news for rural and remote Australians who suffer a stroke.

New technique can help predict and combat potential pandemic virus

By developing a new technique for labeling the gene segments of influenza viruses, researchers now know more about how influenza viruses enter the cell and establish cell co-infections - a major contributing factor to potential pandemic development.

Read more News

› Verified 2 days ago

Psychiatry & Neurology in Milwaukee, WI

Affirmative Reaction
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 6001 W Center St Ste 201, Milwaukee, WI 53210
Phone: 414-324-5318    
Stepping Stone Behavorial Health Clinic, Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 7441 W Greenfield Ave, Suite 15, Milwaukee, WI 53214
Phone: 262-951-6969    
River's Shore Clinic
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 3707 N Richards St, Milwaukee, WI 53212
Phone: 414-967-7006    Fax: 414-967-7020
Sj Counseling Services, Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 7726 N 80th St, Milwaukee, WI 53223
Phone: 414-841-5648    
Westcare Wisconsin, Inc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 335 W Wright St, Milwaukee, WI 53212
Phone: 414-323-0185    
Findley Medical Clinic
Mental Health Clinic
Medicare: Medicare Enrolled
Practice Location: 6114 W Capitol Dr Ste 101, Milwaukee, WI 53216
Phone: 414-988-3079    Fax: 414-982-1211

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.